The Trump administration has reset U.S. nutrition policy, emphasizing high-quality foods and reducing processed options. Discover how these changes could improve American health and lower healthcare costs!
Farmers across the U.S. are grappling with skyrocketing health insurance costs as enhanced subsidies expire, forcing many to choose between their livelihoods and coverage. With rising prices and economic uncertainty, the future looks grim for agricultural workers.
As ACA subsidies near expiration, the Senate's upcoming vote on health care bills is expected to fail, leaving millions at risk of skyrocketing premiums. Both parties are at odds, with urgent calls for a three-year extension.
After 34 days of a federal government shutdown, Senate leaders are cautiously optimistic about a potential resolution. Discussions are underway that may lead to an end to the stalemate affecting millions.
In a bold move, Trump calls for the Senate to eliminate the filibuster to end the government shutdown, igniting fierce debate as Americans face rising food insecurity and healthcare costs.
In a bold move to reduce U.S. prescription drug prices, AstraZeneca and Pfizer have struck deals with the White House, promising significant discounts for patients. This comes amid rising pressure from President Trump on drugmakers to lower costs or face hefty tariffs. Will these changes truly benefit American patients?
In a bold move, Rep. Marjorie Taylor Greene diverges from GOP leadership, urging immediate action on rising health care costs amid the looming government shutdown. Her fierce critique highlights a growing divide within the party as she fights for solutions.
As the government shutdown continues, lawmakers face a critical decision on extending subsidies for the Affordable Care Act. With millions at stake, the urgency mounts for bipartisan action before open enrollment begins.
Many older Americans on Medicare are shocked to find that the newly approved Covid shots aren't covered, leading to hefty out-of-pocket expenses. Health officials claim coverage should be available, but patients report otherwise. What's going on?
A new study warns that superbugs could lead to millions of deaths and nearly $2 trillion in economic losses by 2050. The alarming rise in antimicrobial resistance demands urgent action from governments worldwide.